Devonian Health Group Inc. Plans NYSE American Listing
Devonian Health Group Inc. has announced its intention to list its common shares and warrants on the NYSE American exchange. The listing is set to occur in connection with an underwritten public offering.
Devonian Health Group Inc., based in Quebec, has announced its anticipation of commencing trading on the NYSE American exchange. The company's common shares and warrants will be offered as part of an underwritten public offering, a move intended to broaden its investor base and enhance its market presence.
The company is currently traded on the TSX Venture Exchange under the symbol GSD and also on the OTCQB market under the symbol DVHGF. Listing on the NYSE American is a significant step that typically requires adherence to stricter listing standards and aims to provide greater liquidity and visibility.
Devonian Health Group is involved in the development and commercialization of products within the medical cannabis sector. The planned listing is expected to support the company's ongoing operations and future growth initiatives, potentially facilitating access to capital for expansion.
No specific date for the commencement of trading has been provided, but the company indicated that the listing is contingent upon the completion of the offering and fulfillment of all regulatory and exchange requirements. Further details are expected to be released as the process moves forward.